Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
12.86
-1.56 (-10.82%)
At close: Apr 28, 2026, 4:00 PM EDT
13.24
+0.38 (2.92%)
Pre-market: Apr 29, 2026, 9:09 AM EDT
Avalo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -78.26 | -35.13 | -31.54 | -41.66 | -84.38 | |
| Depreciation & Amortization | 0.34 | 0.17 | 0.16 | 0.17 | 1.66 | |
| Other Amortization | - | - | 1.83 | 1.39 | 0.79 | |
| Asset Writedown & Restructuring Costs | - | 27.64 | 3.91 | - | - | |
| Loss (Gain) From Sale of Investments | -0.69 | - | - | - | - | |
| Stock-Based Compensation | 13.62 | 5.85 | 3.48 | 7.55 | 8.17 | |
| Other Operating Activities | 9.69 | -42.88 | 0.73 | 5.86 | 0.02 | |
| Change in Accounts Receivable | - | - | - | 1.06 | 1.12 | |
| Change in Inventory | - | - | 0.02 | 0.02 | -0.04 | |
| Change in Accounts Payable | -0.15 | -0.16 | -2.44 | -0.49 | 0.8 | |
| Change in Unearned Revenue | - | - | -0.09 | 0.09 | - | |
| Change in Other Net Operating Assets | 3.99 | -4.55 | -6.74 | -0.74 | 0.96 | |
| Operating Cash Flow | -51.46 | -49.06 | -30.68 | -26.75 | -70.89 | |
| Capital Expenditures | - | - | -0.16 | -0.1 | -0.11 | |
| Sale of Property, Plant & Equipment | - | - | 0.03 | - | - | |
| Cash Acquisitions | - | 0.36 | - | - | - | |
| Investment in Securities | -81.72 | - | - | - | - | |
| Investing Cash Flow | -81.72 | 0.36 | -0.13 | -0.1 | -0.11 | |
| Long-Term Debt Issued | - | - | - | - | 32.9 | |
| Long-Term Debt Repaid | - | - | -21.24 | -14.81 | - | |
| Net Debt Issued (Repaid) | - | - | -21.24 | -14.81 | 32.9 | |
| Issuance of Common Stock | 15.56 | 185.07 | 46.29 | 0.11 | 73.86 | |
| Repurchase of Common Stock | -0.51 | - | - | - | - | |
| Other Financing Activities | -0.46 | -9.22 | - | - | - | |
| Financing Cash Flow | 14.59 | 175.85 | 25.04 | -14.7 | 106.76 | |
| Net Cash Flow | -118.59 | 127.15 | -5.77 | -41.55 | 35.76 | |
| Free Cash Flow | -51.46 | -49.06 | -30.84 | -26.85 | -71.01 | |
| Free Cash Flow Margin | -87216.95% | -11123.81% | -1602.81% | -148.72% | -1315.39% | |
| Free Cash Flow Per Share | -3.84 | -6.54 | -111.04 | -684.81 | -1961.95 | |
| Cash Interest Paid | - | - | 1.93 | 2.93 | 1.59 | |
| Levered Free Cash Flow | -17.26 | -16.08 | -17.49 | -12.04 | -37.89 | |
| Unlevered Free Cash Flow | -17.26 | -16.08 | -17.18 | -10.82 | -37.19 | |
| Change in Working Capital | 3.84 | -4.71 | -9.24 | -0.06 | 2.84 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.